Skip to main content
HR 8440 117th Congress House Health

Right to Try Clarification Act

Introduced: July 20, 2022 See on congress.gov
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Jul 20, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 20, 2022
Sponsor introductory remarks on measure. (CR E757)
Jul 20, 2022
Introduced in House
 Plain-English summary Congressional Research Service

Right to Try Clarification Act

This bill specifies that investigational drugs that are provided directly to individuals from manufacturers without the need for federal regulatory approval (i.e., via the Right to Try pathway) are exempt from restrictions that would otherwise apply under the Controlled Substances Act (e.g., restrictions on the use or possession of schedule I controlled substances).

What's happening now November 1, 2022

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

 Committees of jurisdiction 3